BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23843463)

  • 1. Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties.
    Viskov C; Elli S; Urso E; Gaudesi D; Mourier P; Herman F; Boudier C; Casu B; Torri G; Guerrini M
    J Biol Chem; 2013 Sep; 288(36):25895-25907. PubMed ID: 23843463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue.
    Guerrini M; Guglieri S; Casu B; Torri G; Mourier P; Boudier C; Viskov C
    J Biol Chem; 2008 Sep; 283(39):26662-75. PubMed ID: 18640975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
    Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
    Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site.
    Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K
    J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
    Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antithrombotic oligosaccharides].
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.
    Guerrini M; Elli S; Gaudesi D; Torri G; Casu B; Mourier P; Herman F; Boudier C; Lorenz M; Viskov C
    J Med Chem; 2010 Nov; 53(22):8030-40. PubMed ID: 21028827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.
    Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J
    Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
    Desai UR; Petitou M; Björk I; Olson ST
    Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturated tetrasaccharide profile of enoxaparin. An additional piece to the heparin biosynthesis puzzle.
    Gardini C; Bisio A; Mazzini G; Guerrini M; Naggi A; Alekseeva A
    Carbohydr Polym; 2021 Dec; 273():118554. PubMed ID: 34560966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.
    Johnson DJ; Li W; Adams TE; Huntington JA
    EMBO J; 2006 May; 25(9):2029-37. PubMed ID: 16619025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a pure octadecasaccharide with antithrombin activity from an ultra-low-molecular-weight heparin.
    Mourier PA; Guichard OY; Herman F; Viskov C
    Anal Biochem; 2014 May; 453():7-15. PubMed ID: 24561026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new synthetic pentasaccharide with increased anti-factor Xa activity: possible role for anionic clusters in the interaction of heparin and antithrombin III.
    Petitou M; Lormeau JC; Choay J
    Semin Thromb Hemost; 1991; 17 Suppl 2():143-6. PubMed ID: 1948084
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition and Conformational Properties of an Alternative Antithrombin Binding Sequence Obtained by Chemoenzymatic Synthesis.
    Stancanelli E; Elli S; Hsieh PH; Liu J; Guerrini M
    Chembiochem; 2018 Mar; ():. PubMed ID: 29573524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.